Literature DB >> 7762978

Structure of the human deoxyribonuclease I (DNase I) gene: identification of the nucleotide substitution that generates its classical genetic polymorphism.

T Yasuda1, K Kishi, Y Yanagawa, A Yoshida.   

Abstract

The objectives of this study were to elucidate the structural organization of the gene for human deoxyribonuclease I (DNase I) and to identify the mutation site underlying its classical genetic polymorphism. In order to determine the organization of this gene, we utilized a combination of direct polymerase chain reaction (PCR)-amplification of human genomic DNA and isolation of the overlapping clones from a cosmid human genomic library. Restriction endonuclease mapping, Southern blotting and DNA sequencing showed that the DNase I gene was approximately 3.2 kilobases long, it comprised 9 (I-IX) exons separated by eight introns and its complete sequence was determined. The first exon contained only the non-translated sequences of mRNA. In addition to several putative regulatory elements, TATA-like and CAAT-like sequences were observed in the region upstream of the translation initiation codon. These results provide information that will help to understand the expression and regulation of DNase I. The isoelectric focusing patterns of human DNase I showed that it exhibits classical genetic polymorphism (Kishi et al. 1989, 1990). A comparison of the entire translated sequences of the DNase I gene from two pairs of individuals with common DNase I phenotypes 1 and 2 revealed only one nucleotide residue difference in exon VIII, A for phenotype 1 and G for phenotype 2, thus producing Gln and Arg amino acid substitutions respectively at position 222 from the NH2-terminus of the mature enzyme. The predicted charge changes attributable to these amino acid substitutions are entirely consistent with the isoelectric focusing profiles of these two DNase I isozymes. We conclude that this substitution is solely responsible for the classical polymorphism of DNase I protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762978     DOI: 10.1111/j.1469-1809.1995.tb01601.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  6 in total

1.  Amphibian DNases I are characterized by a C-terminal end with a unique, cysteine-rich stretch and by the insertion of a serine residue into the Ca2+-binding site.

Authors:  H Takeshita; T Yasuda; R Iida; T Nakajima; S Mori; K Mogi; Y Kaneko; K Kishi
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Rabbit DNase I: purification from urine, immunological and proteochemical characterization, nucleotide sequence, expression in tissues, relationships with other mammalian DNases I and phylogenetic analysis.

Authors:  T Yasuda; H Takeshita; T Nakajima; O Hosomi; Y Nakashima; K Kishi
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

3.  Identification of the functional alleles of the nonsynonymous single-nucleotide polymorphisms potentially implicated in systemic lupus erythematosus in the human deoxyribonuclease I gene.

Authors:  Kaori Kimura-Kataoka; Misuzu Ueki; Haruo Takeshita; Junko Fujihara; Reiko Iida; Yasuyuki Kawai; Toshihiro Yasuda
Journal:  DNA Cell Biol       Date:  2014-05-12       Impact factor: 3.311

4.  Deoxyribonuclease I gene polymorphism and susceptibility to systemic lupus erythematosus.

Authors:  Milad Mohammadoo-Khorasani; Mahsa Musavi; Mahdieh Mousavi; Maryam Moossavi; Maryam Khoddamian; Mahnaz Sandoughi; Zahra Zakeri
Journal:  Clin Rheumatol       Date:  2015-11-07       Impact factor: 2.980

Review 5.  Deoxyribonucleases and Their Applications in Biomedicine.

Authors:  Lucia Lauková; Barbora Konečná; Ľubica Janovičová; Barbora Vlková; Peter Celec
Journal:  Biomolecules       Date:  2020-07-11

6.  Significant Association of DNASE1 Variable Number Tandem Repeats and Single Nucleotide Polymorphisms With Gastric Cancer.

Authors:  Ali Kafil; Parisa Mohamadynejad; Mehdi Moghanibashi
Journal:  Br J Biomed Sci       Date:  2022-05-13       Impact factor: 2.432

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.